neuropeptide FF [Ligand Id: 1479] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL429731
  • NPFF1 receptor/Neuropeptide FF receptor 1 in Human [ChEMBL: CHEMBL5951] [GtoPdb: 300] [UniProtKB: Q9GZQ6]
There should be some charts here, you may need to enable JavaScript!
  • NPFF2 receptor/Neuropeptide FF receptor 2 in Human [ChEMBL: CHEMBL5952] [GtoPdb: 301] [UniProtKB: Q9Y5X5]
  • NPFF2 receptor/Neuropeptide FF receptor 2 in Mouse [ChEMBL: CHEMBL4523416] [GtoPdb: 301] [UniProtKB: Q924H0]
  • NPFF2 receptor/Neuropeptide FF receptor 2 in Rat [ChEMBL: CHEMBL3425] [GtoPdb: 301] [UniProtKB: Q9EQD2]
There should be some charts here, you may need to enable JavaScript!
  • MAS1 in Mouse [GtoPdb: 150] [UniProtKB: P30554]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
NPFF1 receptor/Neuropeptide FF receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5951] [GtoPdb: 300] [UniProtKB: Q9GZQ6]
ChEMBL Binding affinity to human NPFFR1 expressed in green monkey COS-7 cell membranes by [125I]-1DMeNPFF radioligand based saturation binding assay B 8.95 pKd 1.13 nM Kd J Med Chem (2020) 63: 12387-12402 [PMID:32673481]
GtoPdb - - 9.9 pKi - - - Eur J Pharmacol (2002) 451: 245-56 [PMID:12242085];
Neuropharmacology (2007) 52: 376-86 [PMID:17011599];
Neuroscience (2002) 115: 349-61 [PMID:12421602]
ChEMBL Displacement of [125I]-1DMeNPFF from recombinant human NPFF1 receptor expressed in CHO cells by TopCount scintillation counting method B 10.22 pKi 0.06 nM Ki J Med Chem (2021) 64: 7555-7564 [PMID:34008968]
ChEMBL Agonist activity at NPFF1R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay F 6.56 pEC50 275.42 nM EC50 J Med Chem (2021) 64: 13394-13409 [PMID:34465090]
ChEMBL Agonist activity at NPFF1R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay F 6.56 pEC50 274 nM EC50 J Med Chem (2021) 64: 13394-13409 [PMID:34465090]
ChEMBL Agonist activity at NPFF1 receptor (unknown origin) expressed in HEK293A cells assessed as inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins F 6.8 pEC50 158.49 nM EC50 Bioorg Med Chem (2019) 27: 630-643 [PMID:30626554]
NPFF2 receptor/Neuropeptide FF receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5952] [GtoPdb: 301] [UniProtKB: Q9Y5X5]
ChEMBL Binding affinity to human NPFFR2 expressed in green monkey COS-7 cell membranes by [125I]-1DMeNPFF radioligand based saturation binding assay B 9.43 pKd 0.37 nM Kd J Med Chem (2020) 63: 12387-12402 [PMID:32673481]
ChEMBL Binding affinity to human NPFFR2 B 9.68 pKd 0.21 nM Kd J Med Chem (2020) 63: 12387-12402 [PMID:32673481]
ChEMBL Displacement of [3H]EYE from human NPFF2 receptor expressed in CHO cell membranes after 1 hr by liquid scintillation spectrophotometric counting B 8.92 pKi 1.2 nM Ki J Med Chem (2016) 59: 1925-1945 [PMID:26824643]
GtoPdb - - 9.7 pKi - - - Neuroscience (2002) 115: 349-61 [PMID:12421602];
Br J Pharmacol (2001) 133: 1-4 [PMID:11325787]
ChEMBL Displacement of [125I]-1DMeNPFF from recombinant human NPFF2 receptor expressed in CHO cells by TopCount scintillation counting method B 10.7 pKi 0.02 nM Ki J Med Chem (2021) 64: 7555-7564 [PMID:34008968]
ChEMBL Agonist activity at human NPFF2 receptor E5.27A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 6.21 pEC50 612 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
ChEMBL Agonist activity at human NPFF2 receptor D6.59A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 6.47 pEC50 341 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
ChEMBL Agonist activity at human NPFF2 receptor Y5.38A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 6.9 pEC50 126 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
ChEMBL Agonist activity at human NPFF2 receptor F/Y7.35A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 6.92 pEC50 119 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
ChEMBL Agonist activity at NPFF2R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay F 7.37 pEC50 42.66 nM EC50 J Med Chem (2021) 64: 13394-13409 [PMID:34465090]
ChEMBL Agonist activity at NPFF2R (unknown origin) expressed in HEK293-A cells assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins in presence of 3-isobutyl-1-methylxanthine followed by forskolin and compound addition by competitive PKA binding assay F 7.37 pEC50 42.4 nM EC50 J Med Chem (2021) 64: 13394-13409 [PMID:34465090]
ChEMBL Agonist activity at NPFF2 receptor (unknown origin) expressed in HEK293A cells assessed as inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins F 7.4 pEC50 39.81 nM EC50 Bioorg Med Chem (2019) 27: 630-643 [PMID:30626554]
ChEMBL Agonist activity at human NPFF2 receptor Y7.33A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 7.48 pEC50 33 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
ChEMBL Agonist activity at human NPFF2 receptor F5.34A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 8.25 pEC50 5.6 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
ChEMBL Agonist activity at human NPFFR2 expressed in CHO cells assessed as inhibition of forskolin-induced intracellular cyclic cAMP accumulation F 8.5 pEC50 3.16 nM EC50 J Med Chem (2020) 63: 12387-12402 [PMID:32673481]
ChEMBL Agonist activity at human NPFF2 receptor H/Q6.69A mutant assessed as [3H]inositol phosphate accumulation after 2 hrs by liquid scintillation counting F 8.57 pEC50 2.7 nM EC50 J Med Chem (2012) 55: 6124-6136 [PMID:22708927]
NPFF2 receptor/Neuropeptide FF receptor 2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523416] [GtoPdb: 301] [UniProtKB: Q924H0]
ChEMBL Displacement of [125I]-1DMeNPFF from mouse NPFF2R receptor by TopCount scintillation counting method B 8.96 pKi 1.1 nM Ki J Med Chem (2021) 64: 7555-7564 [PMID:34008968]
NPFF2 receptor/Neuropeptide FF receptor 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3425] [GtoPdb: 301] [UniProtKB: Q9EQD2]
ChEMBL Binding affinity for NPPF receptor in rat spinal cord membranes using the radioligand [125I]-[Tyr1]NPFF B 9.68 pKi 0.21 nM Ki J Med Chem (1994) 37: 3477-3481 [PMID:7932576]
MAS1 in Mouse [GtoPdb: 150] [UniProtKB: P30554]
GtoPdb - - 6.4 pEC50 400 nM EC50 Cell (2001) 106: 619-32 [PMID:11551509]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]